Does ATORVASTATIN Cause Dyslipidaemia? 155 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 155 reports of Dyslipidaemia have been filed in association with ATORVASTATIN (Atorvastatin calcium). This represents 0.2% of all adverse event reports for ATORVASTATIN.
155
Reports of Dyslipidaemia with ATORVASTATIN
0.2%
of all ATORVASTATIN reports
5
Deaths
32
Hospitalizations
How Dangerous Is Dyslipidaemia From ATORVASTATIN?
Of the 155 reports, 5 (3.2%) resulted in death, 32 (20.6%) required hospitalization, and 31 (20.0%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ATORVASTATIN. However, 155 reports have been filed with the FAERS database.
What Other Side Effects Does ATORVASTATIN Cause?
Type 2 diabetes mellitus (7,556)
Myalgia (7,155)
Drug hypersensitivity (3,929)
Drug ineffective (3,865)
Fatigue (3,439)
Arthralgia (3,338)
Rhabdomyolysis (3,286)
Dyspnoea (3,137)
Nausea (2,888)
Asthenia (2,791)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
PREDNISONE (148)
Which ATORVASTATIN Alternatives Have Lower Dyslipidaemia Risk?
ATORVASTATIN vs ATORVASTATIN\EZETIMIBE
ATORVASTATIN vs ATOSIBAN
ATORVASTATIN vs ATOVAQUONE
ATORVASTATIN vs ATOVAQUONE\PROGUANIL
ATORVASTATIN vs ATRACURIUM